Clinical Trial

A Study of Ramelteon in Chinese Patients With Chronic Insomnia

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the efficacy and safety of Ramelteon in chinese patients with chronic insomnia. Efficacy will be evaluated on objective and subjective sleep parameters.
Trial Details
NCT Number NCT06512363
Lead Sponsor Nanjing Chia-tai Tianqing Pharmaceutical
Conditions Chronic Insomnia
Enrollment 280 participants
Start Date 2024-08
Primary Completion 2026-12 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2024-07-22